Sept 12 (Reuters) - Cardiome Pharma Corp COM.TO :
* Cardiome announces agreement with Basilea for distribution of Zevtera/Mabelio (Ceftobiprole) in Europe and Israel
* Cardiome Pharma- under agreement, Basilea has granted cardiome an exclusive license to commercialize Ceftobiprole in 34 European countries and Israel
* Cardiome Pharma Corp - Cardiome will provide Basilea with upfront payment, additional milestone payments based upon achievement of certain milestones